Compare Merck & Co., Inc. (MRK) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Star Bulk Carriers Corp — how do they compare? Merck & Co., Inc. trades at $145.74 (market cap $351.28B), while Star Bulk Carriers Corp trades at $29.99 (market cap $3.54B). The key difference: Merck & Co., Inc. is far larger — about 99.2× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays the higher dividend (6.17%). Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and Star Bulk Carriers Corp for 24 Days on average.
| MRK | SBLK | |
|---|---|---|
Market Cap | $351.28B | $3.54B |
Volume | 7,969,665 | 1,437,622 |
Sector | Health | Industrials |
52-Week High | $156.43 | $32.49 |
52-Week Low | $82.49 | $16.79 |
Typical Hold Time | 98 Days | 24 Days |
Enterprise Value | $398.04B | $4.22B |
Dividend Yield | 2.39% | 6.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $144.96, up 1.52% today, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with a 72.97% gross margin and 28.07% net income margin for 2025, though its P/E ratio of 113.9 indicates high valuation. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, reflecting strategic growth initiatives amid competitive pressures.
The outlook is mixed: analyst consensus is bullish with a $158.78 price target, but technical indicators and a high P/E suggest near-term caution. Key risks include integration challenges from acquisitions and macroeconomic headwinds affecting pharmaceutical R&D investment. Revenue growth and pipeline execution remain critical for sustained upside.
Star Bulk Carriers (SBLK) trades at $29.86, up 0.57% today, with a bullish technical signal from moving averages and a neutral RSI. The company demonstrates strong fundamentals, with Q2 2026 EPS of $1.21 beating expectations and a net income margin of 23.87%. Recent news highlights insider buying and a declared $0.90 dividend, reflecting confidence in the shipping sector's momentum.
The outlook for SBLK is positive, supported by robust earnings growth, attractive valuation metrics like a P/E of 11.95, and a high analyst buy consensus of 58.34%. Key risks include exposure to volatile shipping rates and macroeconomic pressures, but the company's solid cash flow and dividend policy offer shareholder value. Upside potential hinges on continued operational execution and market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
